Search

everythinglearnresearchcommunity

for

Search:↓

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Women pay more for the same 5% minoxidil foam than men, but prices for liquid solutions are similar.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Male mice with FGF5 mutations grow longer hair than females.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Men and minority groups face higher risks and severe outcomes from SARS-CoV, MERS-CoV, and COVID-19.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Women's facial moisturizers cost more per ounce than men's.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Gender and social factors, not just biology, affect COVID-19 death rates.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Gender affects wool traits in sheep, with males and females showing differences in skin proteins related to wool growth.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

India is seeing more cases of gender incongruence and changes in how it's understood and managed legally and medically.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.